Erasca, Inc.
Current role
ERAS
Charles S. Fuchs, M.D., M.P.H.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Charles S. Fuchs, M.D., M.P.H.
Erasca, Inc. reported in an 8-K filed August 10, 2026 that Charles S. Fuchs, M.D., M.P.H. was appointed President, Research & Development, effective August 10, 2026.
“Effective August 10, 2026, Charles S. Fuchs, M.D., M.P.H., was appointed President, Research & Development of Erasca, Inc. (“the Company”).”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Erasca, Inc. (ERAS)
SEC 8-K
Current2026-08-10–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Erasca, Inc.
Other people whose current roles at this company are on record from its filings.
- Jonathan Lim CEO
- David Chacko CFO
- Ebun S. Garner General Counsel
- Alexander W. Casdin Board Member
- James A. Bristol Board Member
- Jean I. Liu Board Member
- Jean Liu, J.D. Board Member
- Julie Hambleton Board Member
- Michael D. Varney Board Member
- Pratik S. Multani Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.